FDA Commissioner Confirmed Amid Pharmaceutical Industry Ties Controversy
Dr. Robert Califf confirmed as FDA Commissioner by a narrow Senate vote of 50-46, highlighting ongoing concerns about pharmaceutical industry regulatory capture. Historical evidence suggests a systemic ‘revolving door’ between FDA and pharmaceutical companies, with approximately 27% of …
Robert Califf
Senate
FDA Leadership
Pharmaceutical Industry Executives
regulatory-capture
revolving-door
pharmaceutical-industry
conflict-of-interest
senate-confirmation
Read more →